Immunohematologic Reconstitution in Pediatric Patients after T Cell-Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 11, 2010, Pages 1557-1566

  Isgrò, Antonella ^a   Marziali, Marco ^a   Sodani, Pietro ^a   Gaziev, Javid ^a   Erer, Buket ^a   Polchi, Paola ^a   Paciaroni, Katia ^a   Roveda, Andrea ^a   De Angelis, Gioia ^a   Gallucci, Cristiano ^a   Alfieri, Cecilia ^a   Simone, Maria Domenica ^a   Zinno, Francesco ^b   Isacchi, Giancarlo ^b   Adorno, Gaspare ^a   Lanti, Alessandro ^a   Leti, Wilma ^c   Aiuti, Fernando ^c   Fraboni, Daniela ^a   Andreani, Marco ^a   Lucarelli, Guido ^a   more..

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone marrow; Cytokines; Stem cells; Stromal cells; Thalassemia

Indexed keywords

AZATHIOPRINE; BUSULFAN; CD45RA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HYDROXYUREA; INTERLEUKIN 17; L SELECTIN; THIOTEPA; THYMOCYTE ANTIBODY;

ARTICLE; BETA THALASSEMIA; BLOOD; CD3+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CHILD; CHIMERA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DONOR SELECTION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NATURAL KILLER CELL; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD; STROMA CELL; T CELL DEPLETION;

B-LYMPHOCYTES; BETA-THALASSEMIA; BLOOD CELLS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHILD; CHILD, PRESCHOOL; CHIMERA; COLONY-FORMING UNITS ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY, MATERNAL-FETAL; HLA ANTIGENS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-7; KILLER CELLS, NATURAL; LIVING DONORS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTES; MOTHERS; STROMAL CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSPLANTS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957748797     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.05.003     Document Type: Article

References (31)

1. Gaziev D., Galimberti M., Lucarelli G., et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA nonidentical sibling or parent transplants. Bone Marrow Transplant 2000, 25:815-821.
2. Rao S., Peter S.O., Crittenden R.B., Stewart F.M., Ramshaw H.S., Quesenberry P.J. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp Hematol 1997, 25:114-121.
3. Reisner Y., Martelli M.F. Transplantation tolerance induced by " mega dose" CD34+ cell transplant. Exp Hematol 2000, 28:119-127.
4. Reisner Y., Gur H., Reich-Zeliger S., Martelli M.F., Bachar-Lusting E. Hematopoietic stem cell transplantation across major genetic barriers. Ann N Y Acad Sci 2005, 1044:70-83.
5. Ruggeri L., Mancusi A., Burchielli E., et al. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis 2008, 40:84-90.
6. Dexter T.M., Lajtha L.G. Proliferation of haemopoietic stem cells in vitro. Br J Haematol 1974, 28. 525-530.
7. Gordon M.Y., Ripley G.P., Watt S.M., Greaves M.F. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987, 326:403-405.
8. Marziali M., De Santis W., Carello R., et al. T cell homeostasis alteration in HIV-1 infected subjects with low CD4+ T-cell count despite undetectable virus load during HAART. AIDS 2006, 20:2033-2041.
9. Isgrò A., Marziali M., Mezzaroma I., et al. Bone marrow clonogenic capability, cytokine production and thymic output in patients with common variable immunodeficiency. J Immunol 2005, 174:5074-5078.
10. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
11. Ichinohe T., Maruya E., Saji H. Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation?. Int J Hematol 2002, 76:229-237.
12. Polchi P., Lucarelli G., Galimberti M., et al. Haploidentical bone marrow transplantation from mother to child with advanced leukemia. Bone Marrow Transplant 1995, 16:529-535.
13. Reisner Y., Martelli M.F. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995, 16:437-440.
14. Kernan N.A., Collins N.H., Juliano L., Cartagena T., Dupont B., O'Reilly R.J. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986, 68:770-773.
15. Di Rosa F., Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol 2005, 26:360-366.
16. + T cells. Blood 2005, 105:1484-1491.
17. Cline M.J., Golde D.W. Immune suppression of hematopoiesis. Am J Med 1978, 64:301-310.
18. Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
19. Roberts R., Gallagher J., Spooncer E., Allen T.D., Bloomfield F., Dexter T.M. Heparin sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988, 332:376-378.
20. Di Rosa F. T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. Immunol Cell Biol 2009, 87:20-29.
21. Sudo T., Ito M., Ogawa Y., et al. Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med 1989, 170:333-338.
22. Tan J.T., Dudl E., LeRoy E., et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001, 96:8732-8737.
23. Mackall C.L., Fry T.J., Bare C., Morgan P., Galbraith A., Gress R.E. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone-marrow transplantation. Blood 2001, 97:1491-1497.
24. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006, 6:93-106.
25. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005, 11:389-398.
26. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313.
27. Ball L.M., Bernardo M.E., Roelofs H., et al. Co-transplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haplo-identical hematopoietic stem cell transplantation. Blood 2007, 110:2764-2777.
28. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005, 23:3447-3454.
29. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
30. Della Chiesa M., Vitale M., Carlomagno S., Ferlazzo G., Moretta L., Moretta A. The natural killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer IG-like receptors. Eur J Immunol 2003, 33:1657-1666.
31. Sodani P., Isgrò A., Gaziev J., et al. Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood 2010, 115:1296-1302.